Pathophysiology of malignant meningiomas

Marcus L. Ware, Alfredo Quinones-Hinojosa, Michael W. McDermott

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Although most meningiomas are benign and are treated with surgery alone, a few are malignant and can be difficult to treat. These more aggressive tumors were first characterized by their histology. With advances in molecular biology, we have learned a great deal about the development of these tumors. Cytogenetic studies have shown that benign meningiomas have mutations in chromosome 22. Further studies show that the NF2 gene, located on chromosome 22, is involved in meningioma formation. More aggressive tumors have been shown to have several mutations in other chromosomes, including chromosome 1p, 14q, and 18q. Here, we review these findings and the candidate genes involved in meningioma tumorigenesis.

Original languageEnglish (US)
Pages (from-to)187-192
Number of pages6
JournalSeminars in Neurosurgery
Volume14
Issue number3
DOIs
StatePublished - Sep 2003
Externally publishedYes

Fingerprint

Meningioma
Chromosomes, Human, Pair 22
Chromosomes
Neoplasms
Mutation
Cytogenetics
Genes
Molecular Biology
Histology
Carcinogenesis

Keywords

  • ALPL
  • DAL-1
  • Malignant meningioma
  • Merlin
  • NF2

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Pathophysiology of malignant meningiomas. / Ware, Marcus L.; Quinones-Hinojosa, Alfredo; McDermott, Michael W.

In: Seminars in Neurosurgery, Vol. 14, No. 3, 09.2003, p. 187-192.

Research output: Contribution to journalReview article

Ware, Marcus L. ; Quinones-Hinojosa, Alfredo ; McDermott, Michael W. / Pathophysiology of malignant meningiomas. In: Seminars in Neurosurgery. 2003 ; Vol. 14, No. 3. pp. 187-192.
@article{d6569748820c46109e69c76e11d32b64,
title = "Pathophysiology of malignant meningiomas",
abstract = "Although most meningiomas are benign and are treated with surgery alone, a few are malignant and can be difficult to treat. These more aggressive tumors were first characterized by their histology. With advances in molecular biology, we have learned a great deal about the development of these tumors. Cytogenetic studies have shown that benign meningiomas have mutations in chromosome 22. Further studies show that the NF2 gene, located on chromosome 22, is involved in meningioma formation. More aggressive tumors have been shown to have several mutations in other chromosomes, including chromosome 1p, 14q, and 18q. Here, we review these findings and the candidate genes involved in meningioma tumorigenesis.",
keywords = "ALPL, DAL-1, Malignant meningioma, Merlin, NF2",
author = "Ware, {Marcus L.} and Alfredo Quinones-Hinojosa and McDermott, {Michael W.}",
year = "2003",
month = "9",
doi = "10.1055/s-2004-817735",
language = "English (US)",
volume = "14",
pages = "187--192",
journal = "Seminars in Neurosurgery",
issn = "1526-8012",
publisher = "Thieme Medical Publishers",
number = "3",

}

TY - JOUR

T1 - Pathophysiology of malignant meningiomas

AU - Ware, Marcus L.

AU - Quinones-Hinojosa, Alfredo

AU - McDermott, Michael W.

PY - 2003/9

Y1 - 2003/9

N2 - Although most meningiomas are benign and are treated with surgery alone, a few are malignant and can be difficult to treat. These more aggressive tumors were first characterized by their histology. With advances in molecular biology, we have learned a great deal about the development of these tumors. Cytogenetic studies have shown that benign meningiomas have mutations in chromosome 22. Further studies show that the NF2 gene, located on chromosome 22, is involved in meningioma formation. More aggressive tumors have been shown to have several mutations in other chromosomes, including chromosome 1p, 14q, and 18q. Here, we review these findings and the candidate genes involved in meningioma tumorigenesis.

AB - Although most meningiomas are benign and are treated with surgery alone, a few are malignant and can be difficult to treat. These more aggressive tumors were first characterized by their histology. With advances in molecular biology, we have learned a great deal about the development of these tumors. Cytogenetic studies have shown that benign meningiomas have mutations in chromosome 22. Further studies show that the NF2 gene, located on chromosome 22, is involved in meningioma formation. More aggressive tumors have been shown to have several mutations in other chromosomes, including chromosome 1p, 14q, and 18q. Here, we review these findings and the candidate genes involved in meningioma tumorigenesis.

KW - ALPL

KW - DAL-1

KW - Malignant meningioma

KW - Merlin

KW - NF2

UR - http://www.scopus.com/inward/record.url?scp=2442657983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442657983&partnerID=8YFLogxK

U2 - 10.1055/s-2004-817735

DO - 10.1055/s-2004-817735

M3 - Review article

VL - 14

SP - 187

EP - 192

JO - Seminars in Neurosurgery

JF - Seminars in Neurosurgery

SN - 1526-8012

IS - 3

ER -